Orexins are lateral hypothalamic neuropeptides that have a highly important role in the regulation of wakefulness.
To support feeding behaviour, orexin neurons are excited by food-related cues and/or low energy balance through neuronal connections with the limbic system and through factors that indicate energy balance.
Orexins simultaneously increase food intake and energy expenditure, but the net effect of increasing orexinergic tone is a decrease in body weight.
Emotive information from the limbic system excites orexin neurons to increase sympathetic outflow to regulate the cardiovascular function.
Orexins play an important part in the formation of cued fear memory through activation of noradrenergic neurons in the locus coeruleus.
Cues and contexts associated with rewards, including food, sex and drugs, influence the activity of orexin neurons to evoke behaviours in response to these stimuli.
Orexins are essential in reward seeking: they do not influence the primary reinforcing or priming effects of rewards, but they support motivated behaviour.
Orexin receptor type 2 (OX2R) has been thought to have a major role in maintaining wakefulness, but orexin receptor type 1 (OX1R) is likely to be involved in a broad range of functions, including emotion, reward and autonomic regulation.
Orexin-producing neurons reside in the lateral hypothalamic area and link forebrain structures — such as the amygdala, bed nucleus of the stria terminalis and nucleus accumbens — that are implicated in the processing of emotion and motivation with brain-stem regions that regulate wakefulness and reward.
Wakefulness and vigilance levels are required for maintaining purposeful activities and motivated behaviours, which are often triggered by sensory information conveying external cues. An increasing body of work has suggested that orexins (also known as hypocretins) — a pair of neuropeptides that are crucial for maintaining wakefulness — are also involved in the regulation of motivated behaviours, including feeding, emotional behaviour and reward seeking, and that these functions are mediated by two subtypes of orexin receptors. Autonomic and endocrine responses, which accompany these motivated behaviours, are also influenced by the orexin system. Orexin-producing neurons act as a hub that links information about the internal and external environments of an animal to vigilance levels and internal bodily functions to support various motivated behaviours.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Sakurai, T. & Mieda, M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 32, 451–462 (2011).
Etori, K., Saito, Y. C., Tsujino, N. & Sakurai, T. Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice. Front. Neurosci. 8, 8 (2014).
Harris, G. C., Wimmer, M. & Aston-Jones, G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437, 556–559 (2005). This work demonstrated, for the first time, roles for orexin neurons and VTA orexin receptors in reward-based learning and memory.
Haynes, A. C. et al. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96, 45–51 (2000).
Aston-Jones, G. et al. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res. 1314, 74–90 (2010).
Harris, G. C. & Aston-Jones, G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29, 571–577 (2006).
Aston-Jones, G., Smith, R. J., Moorman, D. E. & Richardson, K. A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 (Suppl. 1), 112–121 (2009).
Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585 (1998). This study details the discovery of orexins and their two target receptors, the determination of their exact structures and the demonstration that the peptides stimulate short-term food intake.
Anand, B. K. & Brobeck, J. R. Localization of a “feeding center” in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 77, 323–324 (1951).
Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nature Rev. Neurosci. 8, 171–181 (2007).
Yamada, H., Okumura, T., Motomura, W., Kobayashi, Y. & Kohgo, Y. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem. Biophys. Res. Commun. 267, 527–531 (2000).
Sharf, R. et al. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol. Psychiatry 67, 753–760 (2010).
Hara, J., Yanagisawa, M. & Sakurai, T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci. Lett. 380, 239–242 (2005).
Willie, J. T., Chemelli, R. M., Sinton, C. M. & Yanagisawa, M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24, 429–458 (2001).
Funato, H. et al. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell. Metab. 9, 64–76 (2009). This work showed that overexpression of orexin or stimulation of OX2R confers resistance to high-fat diet-induced obesity.
Yamanaka, A. et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713 (2003). This study showed that the activity of orexin neurons could be influenced by circulating factors that are indicative of energy balance, including glucose, ghrelin and leptin. It also demonstrated that orexin neurons are necessary to evoke the appropriate behaviour when animals face starvation.
Mieda, M. & Sakurai, T. Overview of orexin/hypocretin system. Prog. Brain Res. 198, 5–14 (2012).
Burdakov, D., Gerasimenko, O. & Verkhratsky, A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci. 25, 2429–2433 (2005).
Venner, A. et al. Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels. J. Physiol. 589, 5701–5708 (2011).
Chang, G. Q., Karatayev, O., Davydova, Z. & Leibowitz, S. F. Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology 145, 3904–3912 (2004).
Karnani, M. M. et al. Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron 72, 616–629 (2011).
Elias, C. F. et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 402, 442–459 (1998).
van den Pol, A. N., Acuna-Goycolea, C., Clark, K. R. & Ghosh, P. K. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42, 635–652 (2004).
Shiraishi, T., Oomura, Y., Sasaki, K. & Wayner, M. J. Effects of leptin and orexin-A on food intake and feeding related hypothalamic neurons. Physiol. Behav. 71, 251–261 (2000).
Yamanaka, A. et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 859, 404–409 (2000).
Niimi, M., Sato, M. & Taminato, T. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine 14, 269–273 (2001).
Dube, M. G., Kalra, S. P. & Kalra, P. S. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res. 842, 473–477 (1999).
Thorpe, A. J., Mullett, M. A., Wang, C. & Kotz, C. M. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1409–R1417 (2003).
Sweet, D. C., Levine, A. S., Billington, C. J. & Kotz, C. M. Feeding response to central orexins. Brain Res. 821, 535–538 (1999).
Baird, J. P. et al. Orexin-A hyperphagia: hindbrain participation in consummatory feeding responses. Endocrinology 150, 1202–1216 (2009).
Thorpe, A. J. & Kotz, C. M. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res. 1050, 156–162 (2005).
Borgland, S. L. et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29, 11215–11225 (2009).
Borgland, S. L., Ungless, M. A. & Bonci, A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res. 1314, 139–144 (2010).
Thorpe, A. J., Teske, J. A. & Kotz, C. M. Orexin A-induced feeding is augmented by caloric challenge. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R367–R372 (2005).
Choi, D. L., Davis, J. F., Fitzgerald, M. E. & Benoit, S. C. The role of orexin-A in food motivation, reward-based feeding behavior and food-induced neuronal activation in rats. Neuroscience 167, 11–20 (2010).
Zheng, H., Patterson, L. M. & Berthoud, H. R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J. Neurosci. 27, 11075–11082 (2007).
Nair, S. G., Golden, S. A. & Shaham, Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br. J. Pharmacol. 154, 406–416 (2008).
Petrovich, G. D., Hobin, M. P. & Reppucci, C. J. Selective Fos induction in hypothalamic orexin/hypocretin, but not melanin-concentrating hormone neurons, by a learned food-cue that stimulates feeding in sated rats. Neuroscience 224, 70–80 (2012).
Berthoud, H. R. Mind versus metabolism in the control of food intake and energy balance. Physiol. Behav. 81, 781–793 (2004).
Reid, M. S. et al. Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines. Exp. Neurol. 151, 89–104 (1998).
Schuld, A., Hebebrand, J., Geller, F. & Pollmacher, T. Increased body-mass index in patients with narcolepsy. Lancet 355, 1274–1275 (2000).
Hara, J. et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345–354 (2001).
Krahn, L. E., Moore, W. R. & Altchuler, S. I. Narcolepsy and obesity: remission of severe cataplexy with sibutramine. Sleep Med. 2, 63–65 (2001).
Perez-Leighton, C. E., Boland, K., Billington, C. J. & Kotz, C. M. High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats. Obesity 21, 353–360 (2013).
Nakamura, T. et al. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873, 181–187 (2000).
Shiuchi, T. et al. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell. Metab. 10, 466–480 (2009).
Madden, C. J., Tupone, D. & Morrison, S. F. Orexin modulates brown adipose tissue thermogenesis. Biomol. Concepts 3, 381–386 (2012).
Hilton, S. M. The defence-arousal system and its relevance for circulatory and respiratory control. J. Exp. Biol. 100, 159–174 (1982).
Sakurai, T. et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297–308 (2005).
Yoshida, K., McCormack, S., Espana, R. A., Crocker, A. & Scammell, T. E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845–861 (2006). References 49 and 50 used anterograde and retrograde tracers to reveal neurons that send projections to orexin neurons. These studies showed that inputs from the limbic system are likely to have an important role in activating orexin neurons in response to cues that predict fear or reward.
Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996–10015 (1998).
Nambu, T. et al. Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243–260 (1999).
Kayaba, Y. et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R581–R593 (2003).
Zhang, W., Zhang, N., Sakurai, T. & Kuwaki, T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res. 1262, 25–37 (2009). This work showed functional interaction between the extended amygdala and orexin neurons, suggesting that orexin neurons are activated by signals from the extended amygdala.
Zhang, W. et al. Orexin neurons are indispensable for stress-induced thermogenesis in mice. J. Physiol. 588, 4117–4129 (2010).
Zhang, W., Sakurai, T., Fukuda, Y. & Kuwaki, T. Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1654–R1663 (2006).
Dergacheva, O., Philbin, K., Bateman, R. & Mendelowitz, D. Hypocretin-1 (orexin A) prevents the effects of hypoxia/hypercapnia and enhances the GABAergic pathway from the lateral paragigantocellular nucleus to cardiac vagal neurons in the nucleus ambiguus. Neuroscience 175, 18–23 (2011).
Dias, M. B., Li, A. & Nattie, E. E. Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness. J. Physiol. 587, 2059–2067 (2009).
Sansa, G., Iranzo, A. & Santamaria, J. Obstructive sleep apnea in narcolepsy. Sleep Med. 11, 93–95 (2010).
Samson, W. K., Gosnell, B., Chang, J. K., Resch, Z. T. & Murphy, T. C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831, 248–253 (1999).
Shirasaka, T., Nakazato, M., Matsukura, S., Takasaki, M. & Kannan, H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277, R1780–R1785 (1999).
Hirota, K. et al. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res. 981, 143–150 (2003).
Samson, W. K., Bagley, S. L., Ferguson, A. V. & White, M. M. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R382–R387 (2007).
Huang, S. C., Dai, Y. W., Lee, Y. H., Chiou, L. C. & Hwang, L. L. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors. J. Pharmacol. Exp. Ther. 334, 522–529 (2010).
Shahid, I. Z., Rahman, A. A. & Pilowsky, P. M. Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex. Br. J. Pharmacol. 165, 2292–2303 (2012).
de Oliveira, C. V., Rosas-Arellano, M. P., Solano-Flores, L. P. & Ciriello, J. Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am. J. Physiol. Heart Circ. Physiol. 284, H1369–H1377 (2003).
Shih, C. D. & Chuang, Y. C. Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats. Neuroscience 149, 625–635 (2007).
Ciriello, J., Caverson, M. M., McMurray, J. C. & Bruckschwaiger, E. B. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure. Neuroscience 250, 599–613 (2013).
Iigaya, K. et al. Blockade of orexin receptors with Almorexant reduces cardiorespiratory responses evoked from the hypothalamus but not baro- or chemoreceptor reflex responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R1011–R1022 (2012).
Nisimaru, N. et al. Orexin-neuromodulated cerebellar circuit controls redistribution of arterial blood flows for defense behavior in rabbits. Proc. Natl Acad. Sci. USA 110, 14124–14131 (2013).
Furlong, T. M., Vianna, D. M., Liu, L. & Carrive, P. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 30, 1603–1614 (2009).
Steiner, M. A. et al. Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist. ChemMedChem. 8, 898–903 (2013).
Williams, R. H., Jensen, L. T., Verkhratsky, A., Fugger, L. & Burdakov, D. Control of hypothalamic orexin neurons by acid and CO2. Proc. Natl Acad. Sci. USA 104, 10685–10690 (2007).
Johnson, P. L. et al. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol. Behav. 107, 733–742 (2012).
Hess, W. R. & Akert, K. Experimental data on role of hypothalamus in mechanism of emotional behavior. AMA Arch. Neurol. Psychiatry 73, 127–129 (1955).
Johnson, P. L. et al. A key role for orexin in panic anxiety. Nature Med. 16, 111–115 (2010).
Strawn, J. R. & Geracioti, T. D. Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress. Anxiety 25, 260–271 (2008).
Winsky-Sommerer, R. et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24, 11439–11448 (2004).
Tucci, V. et al. Emotional information processing in patients with narcolepsy: a psychophysiologic investigation. Sleep 26, 558–564 (2003).
Ponz, A. et al. Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann. Neurol. 67, 394–398 (2010).
Blouin, A. M. et al. Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nature Commun. 4, 1547 (2013).
Shiromani, P. J., Armstrong, D. M., Berkowitz, A., Jeste, D. V. & Gillin, J. C. Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep 11, 1–16 (1988).
Takakusaki, K. et al. Orexinergic projections to the midbrain mediate alternation of emotional behavioral states from locomotion to cataplexy. J. Physiol. 568, 1003–1020 (2005).
Ishida, Y. et al. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse 45, 46–51 (2002).
Vaiva, G. et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry 54, 947–949 (2003).
Galvez, R., Mesches, M. H. & McGaugh, J. L. Norepinephrine release in the amygdala in response to footshock stimulation. Neurobiol. Learn. Mem. 66, 253–257 (1996).
Mieda, M. et al. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J. Neurosci. 31, 6518–6526 (2011).
Marcus, J. N. et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6–25 (2001).
Soya, S. et al. Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J. Neurosci. 33, 14549–14557 (2013). This work showed that the orexin system modulates the formation and expression of fear memory via OX1R in multiple pathways. In particular, OX1R in LC NA neurons plays an important part in cue-dependent fear-memory formation and/or retrieval.
Steiner, M. A., Lecourt, H. & Jenck, F. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology. 223, 465–475 (2012).
Sears, R. M. et al. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc. Natl Acad. Sci. USA 110, 20260–20265 (2013).
Gozzi, A. et al. Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 6, e16406 (2011).
Khatami, R., Birkmann, S. & Bassetti, C. L. Amygdala dysfunction in narcolepsy–cataplexy. J. Sleep Res. 16, 226–229 (2007).
Boutrel, B. et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl Acad. Sci. USA 102, 19168–19173 (2005). This study suggested a previously unidentified role for orexins in driving drug seeking through the activation of stress pathways in the brain.
Balcita-Pedicino, J. J. & Sesack, S. R. Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and γ-aminobutyric acid neurons. J. Comp. Neurol. 503, 668–684 (2007).
Liu, Z. et al. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron 81, 1360–1374 (2014).
Di Sebastiano, A. R., Wilson-Perez, H. E., Lehman, M. N. & Coolen, L. M. Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Horm. Behav. 59, 1–8 (2011).
Cason, A. M. et al. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol. Behav. 100, 419–428 (2010).
Espana, R. A., Melchior, J. R., Roberts, D. C. & Jones, S. R. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 214, 415–426 (2011).
Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C. & Aston-Jones, G. Multiple roles for orexin/hypocretin in addiction. Prog. Brain Res. 198, 79–121 (2012).
Martin-Fardon, R. & Boutrel, B. Orexin/hypocretin (Orx/Hcrt) transmission and drug-seeking behavior: is the paraventricular nucleus of the thalamus (PVT) part of the drug seeking circuitry? Front. Behav. Neurosci. 6, 75 (2012).
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L. & Bonci, A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49, 589–601 (2006).
Quarta, D., Valerio, E., Hutcheson, D. M., Hedou, G. & Heidbreder, C. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochem. Int. 56, 11–15 (2010).
Winrow, C. J. et al. Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 58, 185–194 (2010).
Hutcheson, D. M. et al. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward. Behav. Pharmacol. 22, 173–1811 (2011).
Sartor, G. C. & Aston-Jones, G. S. A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J. Neurosci. 32, 4623–4631 (2012).
Espana, R. A. et al. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur. J. Neurosci. 31, 336–348 (2010).
Smith, R. J., See, R. E. & Aston-Jones, G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur. J. Neurosci. 30, 493–503 (2009).
Smith, R. J., Tahsili-Fahadan, P. & Aston-Jones, G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58, 179–184 (2010).
James, M. H. et al. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int. J. Neuropsychopharmacol. 14, 684–690 (2011).
Pasumarthi, R. K., Reznikov, L. R. & Fadel, J. Activation of orexin neurons by acute nicotine. Eur. J. Pharmacol. 535, 172–176 (2006).
Plaza-Zabala, A. et al. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 38, 1724–1736 (2013).
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M. & Kenny, P. J. Insular hypocretin transmission regulates nicotine reward. Proc. Natl Acad. Sci. USA 105, 19480–19485 (2008).
LeSage, M. G., Perry, J. L., Kotz, C. M., Shelley, D. & Corrigall, W. A. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology 209, 203–212 (2010).
Georgescu, D. et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23, 3106–3111 (2003).
Sharf, R., Guarnieri, D. J., Taylor, J. R. & DiLeone, R. J. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res. 1317, 24–32 (2010).
Narita, M. et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26, 398–405 (2006).
Richardson, K. A. & Aston-Jones, G. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J. Neurosci. 32, 3809–3817 (2012).
Smith, R. J. & Aston-Jones, G. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur. J. Neurosci. 35, 798–804 (2012).
Moorman, D. E. & Aston-Jones, G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague–Dawley rats. Alcohol 43, 379–386 (2009).
Shoblock, J. R. et al. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 215, 191–203 (2011).
Jupp, B., Krstew, E., Dezsi, G. & Lawrence, A. J. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin(1) receptors. Br. J. Pharmacol. 162, 880–889 (2011).
Lawrence, A. J., Cowen, M. S., Yang, H. J., Chen, F. & Oldfield, B. The orexin system regulates alcohol-seeking in rats. Br. J. Pharmacol. 148, 752–759 (2006).
Dayas, C. V., McGranahan, T. M., Martin-Fardon, R. & Weiss, F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol. Psychiatry 63, 152–157 (2008).
Al-Barazanji, K. A., Wilson, S., Baker, J., Jessop, D. S. & Harbuz, M. S. Central orexin-A activates hypothalamic–pituitary–adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol. 13, 421–424 (2001).
Sakamoto, F., Yamada, S. & Ueta, Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 118, 183–191 (2004).
Winsky-Sommerer, R., Boutrel, B. & de Lecea, L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol. Neurobiol. 32, 285–294 (2005).
Chang, H. et al. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats. Neurosci. Res. 57, 462–466 (2007).
Chou, T. C. et al. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21, RC168 (2001).
Koob, G. F. A role for brain stress systems in addiction. Neuron 59, 11–34 (2008).
Land, B. B. et al. The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system. J. Neurosci. 28, 407–414 (2008).
de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322–327 (1998). This paper relates the independent discovery of the transcript that encodes hypocretins (orexins), the prediction of two peptides encoded by the transcript and the detection of the peptides in dense-core vesicles at synapses.
Date, Y. et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl Acad. Sci. USA 96, 748–753 (1999).
Kukkonen, J. P. & Leonard, C. S. Orexin/hypocretin receptor signalling cascades. Br. J. Pharmacol. 171, 314–331 (2014).
Leonard, C. S. & Kukkonen, J. P. Orexin/hypocretin receptor signalling: a functional perspective. Br. J. Pharmacol. 171, 294–313 (2014).
Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437–451 (1999).
Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376 (1999).
Mochizuki, T. et al. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc. Natl Acad. Sci. USA 108, 4471–4476 (2011).
Brisbare-Roch, C. et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nature Med. 13, 150–155 (2007). This work showed for the first time that a dual orexin receptor antagonist, which blocks both OX1R and OX2R, is effective as a sleep-inducing substance.
Cox, C. D. et al. Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methy l-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J. Med. Chem. 53, 5320–5332 (2010).
Renzulli, C. et al. Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans. Drug Metab. Dispos. 39, 215–227 (2011).
Langmead, C. J. et al. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br. J. Pharmacol. 141, 340–346 (2004).
Porter, R. A. et al. 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorg. Med. Chem. Lett. 11, 1907–1910 (2001).
McAtee, L. C. et al. Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists. Bioorg. Med. Chem. Lett. 14, 4225–4229 (2004).
Fujimoto, T. et al. Discovery of potent, selective, orally active benzoxazepine-based orexin-2 receptor antagonists. Bioorg. Med. Chem. Lett. 21, 6414–6416 (2011).
Malherbe, P. et al. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmet hyl-acetamide (EMPA). Mol. Pharmacol. 78, 81–93 (2010).
Hirose, M. et al. N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg. Med. Chem. Lett. 13, 4497–4499 (2003).
Watabe-Uchida, M., Zhu, L., Ogawa, S. K., Vamanrao, A. & Uchida, N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74, 858–873 (2012).
The author declares no competing financial interests.
A sudden weakening of muscle tone that often accompanies narcolepsy.
A sleep disorder caused by a specific loss of hypothalamic orexin neurons.
Abnormally increased levels of CO2 in the blood.
- Obstructive sleep apnoea syndrome
A condition characterized by repetitive pauses in breathing during sleep (known as apnoeas) caused by obstruction in the upper airway.
- Resident–intruder paradigm
An experimental design in which a new ('intruder') mouse is placed in the home cage of another ('resident') mouse. The effect of the stress is then assessed in the resident mouse.
- Defence response
The visceral and hormonal changes that accompany fear reactions. They are adaptations that prepare an animal to cope with an emergency, and specifically to perform the extreme muscular exertion of flight or attack.
- Pressor response
An increase in arterial blood pressure in response to an internal or external trigger.
An abnormally high heart rate.
An abnormally low heart rate.
- Depressor response
A decrease in arterial blood pressure in response to an internal or external trigger.
- Head-up tilt
A test to find the autonomic response in humans. The test involves lying quietly on a bed and being tilted at different angles (30 to 60 degrees) for a period of time while blood pressure, heart rates and blood-oxygen level are monitored.
- Valsalva manoeuvre
Attempted exhalation against a closed airway: subjects are usually instructed to blow out as if blowing up a balloon while keeping their mouth closed and pinching their nose shut.
- Cold pressor test
A test to assess the effect of cold-water immersion (of all or part of the body) on blood pressure.
Loss of muscle tone.
About this article
Cite this article
Sakurai, T. The role of orexin in motivated behaviours. Nat Rev Neurosci 15, 719–731 (2014). https://doi.org/10.1038/nrn3837
Molecular Brain (2021)
RF-amide related peptide-3 (RFRP-3): a novel neuroendocrine regulator of energy homeostasis, metabolism, and reproduction
Molecular Biology Reports (2021)
Scientific Reports (2020)
Disruption of estradiol regulation of orexin neurons: a novel mechanism in excessive ventilatory response to CO2 inhalation in a female rat model of panic disorder
Translational Psychiatry (2020)
Orexin signaling modulates synchronized excitation in the sublaterodorsal tegmental nucleus to stabilize REM sleep
Nature Communications (2020)